FONDAZIONE TELETHON ANNOUNCES FDA APPROVAL OF WASKYRA™ (ETUVETIDIGENE AUTOTEMCEL), A GENE THERAPY FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME

Reuters · 12/10/2025 12:13

Please log in to view news